Read research from the April 2022 session of the ASCO Plenary Series, which highlights a clinical trial that studied a medication called tislelizumab combined with chemotherapy to treat recurrent or metastatic nasopharyngeal cancer. Read More >>
meetings
April 18, 2022 · Greg Guthrie, ASCO staff
March 31, 2022 · Brielle Gregory Collins, ASCO staff
In this podcast, Dr. Kedar Kirtane discusses research from the 2022 Multidisciplinary Head and Neck Cancers Symposium, including discussions around cancer disparities in head and neck cancer, treatment for HPV-positive oropharyngeal cancer, and strategies for treating HPV-related head and neck cancers. Read More >>
March 14, 2022 · Brielle Gregory Collins, ASCO staff
Read research from the March 2022 session of the ASCO Plenary Series, which highlights an immunotherapy combination to treat advanced melanoma and adding immunotherapy to chemotherapy to treat advanced non-small cell lung cancer. Read More >>
February 14, 2022 · Brielle Gregory Collins, ASCO staff
Research from ASCO’s 2022 Genitourinary Cancers Symposium features a study on predicting the risk of developing and dying from metastatic prostate cancer in a diverse population. Read More >>
February 14, 2022 · Greg Guthrie, ASCO staff
Read research from the February 2022 session of the ASCO Plenary Series, which highlights a study on daily aspirin to prevent breast cancer recurrence and another on using targeted therapy to treat advanced pancreatic cancer with a specific mutation. Read More >>
